Target intelligence / Profile preview

Virus maturation

Molecular classification
Other (represents a viral life cycle stage/process, not a molecule)
01

Overview

Virus maturation is the final, crucial phase in the assembly of many viruses, transforming provirions or immature virions into infectious particles through large-scale structural rearrangements and proteolytic cleavage of viral proteins[2][3][4][5]. This process often involves the activation of viral proteases that modify capsid or envelope proteins, sometimes assisted by host cell enzymes. Viral maturation steps can include capsid protein reorganization, genome condensation, and activation of fusion proteins, and are essential for producing virions capable of infecting new host cells[2][3][4][5]. Disruption of maturation by drugs such as protease inhibitors forms an important antiviral strategy, especially in retroviruses like HIV, where blockage prevents the formation of infectious progeny[2][3]. Virus maturation is thus best considered a process rather than a specific molecule or receptor, and while critical for infectivity and as a therapeutic target, it does not fit typical molecular target classifications used for receptors, enzymes, or transporters.

Other names
Virion maturationViral maturation
02

Mechanism of action

Protease inhibition to block virion maturation (rendering virus particles non-infectious)[2][3]

03

Biological functions

Activation of viral infectivityViral structural protein cleavage/rearrangementGenome packagingPreparation for host cell infectionViral particle stabilization
04

Disease associations

InfectionViral pathogenesis
05

Safety considerations

Resistance due to viral mutations in proteases or maturation-associated proteins[2][3]Host cell toxicity (off-target protease inhibition)Incomplete inhibition resulting in emergence of immature non-infectious but immunogenic particles
06

Interacting drugs

HIV protease inhibitors (e.g., lopinavir, ritonavir, darunavir)[2][3]

2 more in the full profile.

07

Biomarkers

Appearance of mature virion structural components (e.g., processed capsid or envelope proteins, cleaved Gag in HIV[3])Levels of infectious viral particles (versus immature particles)

Beyond the preview

Go deeper on Virus maturation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virus maturation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call